FibroBiologics Files Patent For Novel Approach to Modulate Mitochondrial Activity Using Fibroblast-Based Therapeutics

FibroBiologics, Inc. announced the filing of a patent application with the United States Patent and Trademark Office covering methods employing fibroblasts to improve mitochondrial performance in cells.